Amgen Delves into Protein Degrader Therapies with Plexium Collaboration
By Sasha Yachu
Pharma Deals Review: Vol 2022 Issue 2 (Table of Contents)
Published: 18 Feb-2022
DOI: 10.3833/pdr.v2022.i2.2671 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to enter the protein degradation space, Amgen has entered intoa strategic research collaboration with Plexium to identify and develop targeted protein degradation therapies for historically challenging drug targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS